CSI Market
Sign In | Register

Intellia Therapeutics Inc (NTLA) Annual Balance Sheets

Annual · GAAP · USD millions
Access NTLA quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Intellia Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent155.46
Marketable Securities, Current SH294.42
Cash & Short-term Investments449.00
Accounts receivable9.47
Other Current Assets0.00
Prepaid Expense And Other Assets Current68.36
Total Current Assets527.71
Equipment/Property/Plant Net17.67
Long-term investments35.54
Other Assets, Noncurrent296.75
Operating Lease Right Of Use Asset105.96
Total Assets842.13
Liabilities
Accounts Payable, Current AC20.25
Accrued Liabilities, Current AC49.86
Other Liabilities, Current33.77
Total Current Liabilities103.88
Total Long-term Debt0.00
Other liabilities, Noncurrent66.85
Contract With Customer Liability Current7.29
Contract With Customer Liability Noncurrent-
Total Liabilities170.73
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock3,260.44
Retained Earnings / Accumulated Deficit-2,590.09
Other Equity1.03
Common Stockholder's Equity671.39
Total Stockholder's Equity671.39
Liabilities & Stockholder's Equity842.13
4 historic quarters locked

Sign in to unlock the full Intellia Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Intellia Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: ntla-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076550

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License